However, the expression of TIM-3, a checkpoint inhibitor, was higher in stage 0 of CLL and it was lower in more advanced stages of the disease, suggesting its possible diagnostic value in CLL. The gene discussed is HAVCR2; the disease is B-cell chronic lymphocytic leukemia.